Pacific Biosciences Of California (PACB) Total Debt (QoQ) (2011 - 2023)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Pacific Biosciences Of California | 481.66 Mn | 205.70 Mn | 12.84 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | -48.37% |
| Jun 30, 2023 | 1.07% |
| Mar 31, 2023 | 6.81% |
| Dec 31, 2018 | 1.91% |
| Sep 30, 2018 | 1.86% |
| Jun 30, 2018 | 1.79% |
| Mar 31, 2018 | 1.74% |
| Dec 31, 2017 | 30.40% |
| Sep 30, 2017 | 0.14% |
| Jun 30, 2017 | -21.51% |
| Mar 31, 2017 | -17.41% |
| Dec 31, 2016 | 1.98% |
| Sep 30, 2016 | 1.92% |
| Jun 30, 2016 | 1.84% |
| Mar 31, 2016 | 1.79% |
| Dec 31, 2015 | 0.95% |
| Sep 30, 2015 | 1.65% |
| Jun 30, 2015 | 1.59% |
| Mar 31, 2015 | 2.49% |
| Dec 31, 2014 | 0.55% |
| Sep 30, 2014 | 1.46% |
| Jun 30, 2014 | 1.40% |
| Mar 31, 2014 | 1.33% |
| Dec 31, 2013 | 1.32% |
| Sep 30, 2013 | 1.28% |
| Mar 31, 2012 | -1.06% |
| Dec 31, 2011 | -1.01% |
| Sep 30, 2011 | -1.00% |